JPWO2020239568A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020239568A5
JPWO2020239568A5 JP2021569359A JP2021569359A JPWO2020239568A5 JP WO2020239568 A5 JPWO2020239568 A5 JP WO2020239568A5 JP 2021569359 A JP2021569359 A JP 2021569359A JP 2021569359 A JP2021569359 A JP 2021569359A JP WO2020239568 A5 JPWO2020239568 A5 JP WO2020239568A5
Authority
JP
Japan
Prior art keywords
etoh
methanesulfonylphenoxy
fluoro
propyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021569359A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533433A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/064046 external-priority patent/WO2020239568A1/en
Publication of JP2022533433A publication Critical patent/JP2022533433A/ja
Publication of JPWO2020239568A5 publication Critical patent/JPWO2020239568A5/ja
Pending legal-status Critical Current

Links

JP2021569359A 2019-05-24 2020-05-20 [2-(3-フルオロ-5-メタンスルホニルフェノキシ)エチル](プロピル)アミンの薬学的に許容される塩、およびその使用 Pending JP2022533433A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19176514.8 2019-05-24
EP19176514 2019-05-24
EP20166361.4 2020-03-27
EP20166361 2020-03-27
PCT/EP2020/064046 WO2020239568A1 (en) 2019-05-24 2020-05-20 Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof

Publications (2)

Publication Number Publication Date
JP2022533433A JP2022533433A (ja) 2022-07-22
JPWO2020239568A5 true JPWO2020239568A5 (xx) 2023-05-29

Family

ID=70682855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021569359A Pending JP2022533433A (ja) 2019-05-24 2020-05-20 [2-(3-フルオロ-5-メタンスルホニルフェノキシ)エチル](プロピル)アミンの薬学的に許容される塩、およびその使用

Country Status (19)

Country Link
US (1) US20220267262A1 (xx)
EP (2) EP4292653A3 (xx)
JP (1) JP2022533433A (xx)
KR (1) KR20220011638A (xx)
CN (1) CN113853369A (xx)
AU (1) AU2020286003A1 (xx)
BR (1) BR112021023563A2 (xx)
CA (1) CA3140805A1 (xx)
CL (1) CL2021003115A1 (xx)
CO (1) CO2021016556A2 (xx)
DK (1) DK3976581T3 (xx)
ES (1) ES2970361T3 (xx)
FI (1) FI3976581T3 (xx)
IL (1) IL288271A (xx)
JO (1) JOP20210312A1 (xx)
MX (1) MX2021014271A (xx)
PT (1) PT3976581T (xx)
SG (1) SG11202112165QA (xx)
WO (1) WO2020239568A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220168242A1 (en) * 2020-11-10 2022-06-02 Susanna Holm Waters Pharmaceutically acceptable salts of mesdopetam and uses thereof
WO2024042540A1 (en) * 2022-08-24 2024-02-29 Alkem Laboratories Limited Mesdopetam compositions
WO2024062344A1 (en) 2022-09-21 2024-03-28 Assia Chemical Industries Ltd. Solid state forms of mesdopetam and salts therof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904723D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
EP1899326A4 (en) 2005-06-23 2009-12-16 Albireo Ab NOVEL AZETIDINE DERIVATIVES USEFUL AS ANTAGONISTS OF NEUROKININ RECEPTORS IN THE TREATMENT OF GASTROINTESTINAL DISEASES
CA2687721A1 (en) * 2007-06-08 2008-12-18 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-1-{2-[4'-(3-methoxy-propane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto
TW200932225A (en) * 2007-12-14 2009-08-01 Lundbeck & Co As H 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
MX341847B (es) * 2011-04-19 2016-09-05 Integrative Res Laboratories Sweden Ab Moduladores novedosos de neurotransmision cortical dopaminergica y glutamatergica mediada por receptor de n-metil-d-aspartato.
LT3649124T (lt) * 2017-08-07 2021-06-10 Suven Life Sciences Limited Fluorpiperidino junginiai kaip grynieji 5-ht6 receptorių antagonistai

Similar Documents

Publication Publication Date Title
JP2012500819A5 (xx)
JP2009503034A (ja) 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法
JP2023154056A (ja) エパルレスタットを調製する方法
JP2010510253A5 (xx)
JP2011503053A (ja) 2‐ヒドロキシ‐5‐フェニルアルキルアミノ安息香酸誘導体及びその塩の製造方法
AU731835B2 (en) Method of manufacturing sertindole
JP7379470B2 (ja) レンバチニブの調製方法
JPWO2020239568A5 (xx)
TW212181B (xx)
JP4770826B2 (ja) 2−オキシインドール誘導体の製造法
JPS5821658B2 (ja) エンキセイオキサジンセンリヨウノセイホウ
JP6967143B2 (ja) ガドブトロール中間体及びこれを用いたガドブトロールの製造方法
JP5757665B2 (ja) イマチニブ塩基を調製する新規な方法
JP2015526507A (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法
JP2010502682A5 (xx)
JP6284942B2 (ja) 4−アミノ−2,5−ジメトキシピリミジンから2−アミノ−5,8−ジメトキシ[1,2,4]トリアゾロ[1,5−c]ピリミジンを調製するための改善された方法
JP4433365B2 (ja) 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法
WO2016035405A1 (ja) アゾ色素組成物及びその製造方法
CN107011322A (zh) 一种高纯度脱氢苯基阿夕斯丁类化合物的制备纯化方法
JPS6363658A (ja) 置換インドリノン誘導体の製造法
JP5087059B2 (ja) 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法
JP4078328B2 (ja) 2−オキシインドール誘導体の製造法
JPH072742A (ja) 4−アミノ−3−メチル−N−エチル−N−(β−ヒドロキシエチル)アニリン硫酸塩の新規製造法
CN117126108A (zh) 一种Ensitrelvir中间体的制备方法
CN113480523A (zh) 匹莫苯丹的制备方法